Discover the best AI-focused podcasts for business owners. Stay ahead with expert insights on AI trends, tools, and ...

Gamers in search of a new action-packed co-op experience to check out will want to keep an eye out for this day one Xbox Game ...

Dallas baker Dave Hale's videos are informative and casual, the type that'll inspire a bored doomscroller to get off the ...

The second annual Ulta Beauty World has arrived in Orlando, offering an immersive one-day experience featuring over 200 ...

Alabama football took the field at Bryant-Denny Stadium for the final time in spring. Kalen DeBoer held his final scrimmage ...

Day One continues to offer a free version of its journaling app for iPhone, iPad, and Mac. Apple’s Journal app is the better free option if you want to capture from more than one device or add more ...

Now that the Supreme Court has struck down Trump's "emergency" tariffs, will the government refund the billions of dollars it unlawfully collected? And as Trump turns to other tariff authorities, how ...

Anna Hazare reacts after Raghav Chadha, 6 others quit AAP: 'They must have faced' Did Rakesh Bedi get Rs 1 crore bonus for Dhurandhar 2? His retort, "Kiski jeb mein hai?" This hydrogen stove runs on ...

Servier is expanding its cancer drug prospects through the $2.5 billion acquisition of Day One Biopharmaceuticals, a biotech with a commercialized therapy for a type of pediatric glioma and ...

Servier agreed to acquire Day One Biopharmaceuticals DAWN0.12%increase; green up pointing triangle for $2.5 billion in a push to expand its rare oncology portfolio. Servier will pay $21.50 a share in ...

U.S. cancer drug developer Day One Biopharmaceuticals (DAWN) has agreed to be acquired by French pharmaceutical group Servier in an all-cash deal worth nearly $2.5B, according to a statement from the ...

March 6 (Reuters) - French drugmaker Servier said on Friday it would buy U.S.-based Day One Biopharmaceuticals (DAWN.O), opens new tab for ‌about $2.5 billion, expanding its brain tumor treatment ...